CencoraCOREarnings & Financial Report
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment.
COR Q1 2026 Key Financial Metrics
营收
$85.9B
毛利润
$3.1B
营业利润
$760.4M
净利润
$559.6M
毛利率
3.6%
营业利润率
0.9%
净利率
0.7%
同比增长
13.9%
EPS
$2.87
资金流向
Cencora Q1 2026 Financial Summary
Cencora reported revenue of $85.9B for Q1 2026, with a net profit of $559.6M (0.7% margin). Cost of goods sold was $82.9B, operating expenses totaled $2.3B.
Key Financial Metrics
| Total Revenue | $85.9B |
|---|---|
| Net Profit | $559.6M |
| Gross Margin | 3.6% |
| Operating Margin | 0.9% |
| Report Period | Q1 2026 |
Cencora Annual Revenue by Year
Cencora annual revenue history includes year-by-year totals (for example, 2025 revenue was $322.7B).
| Year | Annual Revenue |
|---|---|
| 2025 | $322.7B |
| 2024 | $298.4B |
| 2023 | $269.6B |
| 2022 | $240.7B |
利润表
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| 营收 | $74.24B | $74.24B | $81.49B | $75.45B | $80.66B | $80.66B | $85.93B | $85.93B |
| 同比增长 | 10.9% | 10.9% | 12.8% | 10.3% | 8.7% | 8.7% | 5.5% | 13.9% |
资产负债表
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| 总资产 | $66.77B | $67.10B | $69.05B | $71.19B | $73.96B | $76.59B | $78.36B | $78.36B |
| 总负债 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 股东权益 | $925.2M | $645.9M | $226.6M | $1.01B | $1.98B | $1.51B | $1.91B | $1.91B |
现金流量表
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| 经营性现金流 | $2.48B | $1.00B | $-2.72B | $3.35B | $109.2M | $3.13B | $-2.31B | $-2.31B |
Other Health Care Companies
CAH
Cardinal Health
营收
$65.6B
净利润
$467.0M
HSIC
Henry Schein
营收
$3.3B
净利润
$101.0M
MCK
McKesson Corporation
营收
$106.2B
净利润
$1.2B
ABT
Abbott Laboratories
营收
$11.4B
净利润
$1.6B
ABBV
AbbVie
营收
$15.8B
净利润
$186.0M
A
Agilent Technologies
营收
$1.9B
净利润
$434.0M
ALGN
Align Technology
营收
$995.7M
净利润
$56.8M
AMGN
Amgen
营收
$9.9B
净利润
$1.3B
BAX
Baxter International
营收
$3.0B
净利润
$-1.1B
BDX
Becton Dickinson
营收
$5.3B
净利润
$382.0M